An article published in the April, 2014 edition of Journal of Sexual Medicine by M. Gacci et al. titled “Impact of Medical Treatments for Male Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia on Ejaculatory Function: A Systematic Review and Meta-Analysis.” provides additional support for finasteride’s link to sexual dysfunction.  Finasteride is the active chemical in Proscar (finasteride 5mg, for benign prostatic hyperplasia – BPH), Propecia (finasteride 1mg, for hair loss), and other drugs, and is in the class of 5alpha-reductase inhibitors (5ARIs).

The authors studied 23 previously-conducted studies and found that ejaculation disorder “was significantly more common with 5ARIs as compared with placebo (OR:2.73; P < 0.0001)”, meaning that use of 5ARIs made one nearly three times as likely to suffer ejaulation disorder compared with placebo users.

It was also found that “Both Finasteride (OR 2.70; P < 0.0001) and Dutasteride (OR 2.81; P = 0.0002) were associated with significantly higher risk of EjD than placebo”, meaning that finasteride itself, not simply that class of drugs, was associated with a dramatically-increased risk for ejaculation disorder (2.7 times the risk).

Because the manufacturers of Proscar and Propecia (Merck & Co., Inc.) have failed to adequately warn users of the risk for such sexual side effects, a number of Proscar lawsuits and Propecia lawsuits have been filed.  If you or a loved one used Proscar or Propecia and suffered ejaculation disorder or another sexual side effect, you may be entitled to significant financial compensation.  For a free, no-obligation case consultation, contact our team of Proscar lawyers and Propecia lawyers at the information provided below.  We have the experience, resources, and skills required to win the justice you deserve.  Call today and see how we can help.

(855) 452 – 5529